Automated and quantitative immunocytochemical assays of Nm23/NDPK protein in breast carcinomas

International Journal of Cancer

Volumn 74, Issue 4, 1997, Pages 416-420

  Charpin, Colette ^a   Bouvier, Corinne ^b   Garcia, Stéphane ^b   Martini, François ^b   Andrac, Lucile ^a   Lavaut, Marie Noëlle ^a   Allasia, Claude ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b HÔPITAL NORD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN D; CD31 ANTIGEN; NUCLEOSIDE DIPHOSPHATE KINASE; TENASCIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BREAST CARCINOMA; CELL PROLIFERATION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; QUANTITATIVE ASSAY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AUTOMATION; BREAST NEOPLASMS; CATHEPSIN D; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LYMPHATIC METASTASIS; MIDDLE AGED; MONOMERIC GTP-BINDING PROTEINS; NEOPLASM METASTASIS; NUCLEOSIDE-DIPHOSPHATE KINASE; P-GLYCOPROTEIN; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TENASCIN; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030880474     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970822)74:4<416::AID-IJC9>3.0.CO;2-Y     Document Type: Article

References (21)

1. BARNES, R., MASOOP, S., BARKER, E., ROSENGARD, A.M., COGGIN, D.L., CROWELL, KINO, C.R., PORTER-JORDAN, K., WARGOTZ, E.S., LIOTTA, L.A. and STEEG, P.S., Low nm23-protein expression in infiltrating ductal breast carcinomas correlates with reduced patient survival. Amer. J. Path., 139, 245-250 (1991).
2. BEVILACQUA, G., SOBEL, M.E., LIOTTA, L.A. and STEEG, P.S., Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph-node involvement and other histopathological indicators of high metastatic potential. Cancer Res., 49, 5185-5190 (1989).
3. CHARPIN, C., DEVICTOR, B., ANDRAC, L., AMABILB, J., BERGERET, D., LAVAUT, M.N., ALLASIA, C. and PIANA, L., P-53 quantitative immunocyto-chemical analysis in breast carcinomas. Hum. Pathol., 26, 159-166 (1995a).
4. CHARPIN, C., DEVICTOR, B., BERGERET, D., ANDRAC, L., BOULAT, J., HORSCHOWSKI, N., LAVAUT, M.N. and PIANA, L., CD31 quantitative immunocytochemical assays in breast carcinomas. Correlation with current prognostic factors. Amer. J. clin. Pathol., 103, 443-448 (1995b).
5. CHARPIN, C., DEVICTOR, B., BONNIER, P., ANDRAC, L., LAVAUT, M.N., ALLASIA, C. and PIANA, L., Cathepsin-D immunocytochemical assays in breast carcinomas: image analysis and correlation to prognostic factors. J. Pathol., 170, 463-470 (1993).
6. CHARPIN, C., VIELH, P., DUFFAUD, F., DEVICTOR, B., ANDRAC, L., LAVAUT, M.N., ALLASIA, C., HORSCHOWSKI, N. and PIANA, L., Quantitative immunocytochemical assays of P-glycoprotein in breast carcinomas: correlation to messenger RNA expression and to immunohistochcmical prognostic indicators. J. nat. Cancer Int., 20, 1539-1545 (1994).
7. ELSTON, C.W. and ELLIS, I.O., Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long term follow-up. Histopathology 19, 403-410 (1991).
8. GALEA, M.H., Nottingham prognostic index in primary breast cancer. Br Cancer Res. Treat., 22, 207-219 (1992).
9. HENNESSY, C., HENRY, J.A., MAY, F.E.B., WESTLEY, B.R., ANGUS, B. and LENNARD, T.W.J., Expression of the anti-metastatic gene nm23 in human breast cancer: an association with good prognosis. J. nat. Cancer Inst., 83, 281-285 (1991).
10. HIRAYAMA, R., SAWAI, S., TAKAGI, Y., MISHIMA, X., KIMURA, N., SHIMADA, N., ESAKI, Y., KURASHIMA UTSUYAMA, M. and HIROKAWA, K., Positive relationship between expression of anti-metastatic factor (nm23-gene product or nucleoside diphosphate kinase) and good prognosis in human breast cancer. J. nat. Cancer Inst., 83, 1249-1250 (1990).
11. HOWLETT, A.R., PETERSEN, O.W., STEEG, P.S. and BISSLL, M.J., A novel function tor nm23-HI gene: over-expression in human breast-carcinoma cells leads to the formation of basement membrane and growth arrest. J. nat. Cancer Inst., 86, 1838-1844 (1994).
12. KANTOR, J.D., MCCORMICK, B., STEEG, P.S. and ZETTER, B.R., Inhibition of cell motility after nm23 transfection of human and murine tumor cells. Cancer Res., 53, 1971-1973 (1993).
13. LACOMBE, M.L., SASTRE-GARAU, X., LASCU, I., VONICA, A., THIERY, J.P. and VERON, M., Over-expression of nucleoside diphosphate kinase (NM23) in solid tumours. Europ. J. Cancer, 27, 1302-1307 (1991).
14. LAKSO, M., STEEG, P.S. and WESTPHAL, H., Embryonic expression of Nm23 during mouse organogenesis. Cell Growth Different, 3, 873-879 (1992).
15. LE DOUSSAL, V. and BRUNET M., Prognostic value of histologic grade nuclear components of Scarff-Bloom-Riehardson (SBR). An improved score modification based on a multivariated analys of 1262 invasive ductal breast carcinomas. Cancer, 64, 1914-1921 (1989).
16. MAC-DONALD, N.J., DE LA ROSA, A., BENEDICT, M.A., FREIE, J.M., KRUTSCH, H. and STEEG, P.S., A serine phosphorylation of Nm23, and not its nucleoside diphosphate kinase activity, correlates with suppression of tumor metastasis. J. biol. Chem., 269, 25780-25789 (1993).
17. MACDONALD, N.J., DE LA ROSA, A. and STEEG, P.S., The potential roles of nm23 in cancer metastasis and cellular differentiation. Europ. J. Cancer, 31A, 1096-1100 (1995).
18. ROYDS, J.A., STEPHENSON, T.J., REES, R.C., SHORTHOUSE, A.J. and SILOCKS, P.B., Nm23-protein expression in ductal in situ and invasive human breast carcinoma. J. nat. Cancer Inst., 85, 727-731 (1993).
19. SASTRE GARAU, X., LACOMBE, M.L., JOUVE, M., VERON, M. and MAGDELENAT, H., Nucleoside diphosphate kinase/Nm23 expression in breast cancer: lack of correlation with lymph-node metastasis. Int. J. Cancer, 50, 533-538 (1992).
20. SAWAN, A., LASCU, I., VERON, M., ANDERSON, J.J., WRIGHT, C., HORNE, C.H.W. and ANGUS, B., NDP-K/nm23 expression in human breast cancer in relation to relapse, survival, and other proenostic factors: an immunohisto-chemical study. J. Pathol. 172, 27-34 (1994).
21. STEEG, P.S., BHVILACQUA, G., KOPPER, L., THORGEIRSSOV, U.P., TALMADGE, J.E., LIOTTA, L.A. and SOBEL, M.A., Evidence for a novel gene associated with low tumor metastatic potential. J. nat. Cancel Inst., 80, 200-204 (1988).